Marco Pupo

Marco holds a background in Pharmaceutical Technology and Biochemistry, bringing over a decade of academic and industry experience in biotechnology R&D. He has successfully coordinated cross-functional teams in matrixed environments, overseeing international programs from proof-of-concept to GMP technology transfer. Marco specializes in process and analytical development for non-viral cell therapies, proteins, and nucleic acid-based therapeutics. An expert inventor in the RNA field, he has pioneered breakthrough single-pot and simultaneous co-transcriptional in vitro capping technologies (AMCAP™) to streamline scale-up and reduce manufacturing bottlenecks for therapeutic mRNA.